Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer

Clinical trial NCT00158886 · TERMINATED

Trial details

NCT number: NCT00158886
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2001-11-08
Primary completion: 2006-08-11
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.